Yumanity Therapeutics, Inc. (YMTX) Income Annual - Discounting Cash Flows
YMTX
Yumanity Therapeutics, Inc.
YMTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
Report Filing 2025-05-15 2025-04-29 2024-03-21 2023-03-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31
Revenue 4.34 0 5.44 1.95 9.09 10.49 5 2.84 5.34 8.38 4.31
Cost of Revenue -2.73 0 0.009 0.734 0.669 0 0 0 0 0 0
Gross Profit 7.07 0 5.43 1.22 8.42 10.49 5 2.84 5.34 8.38 4.31
Operating Expenses 14 13.53 21.16 42.75 19.52 13.6 66.15 66.02 65.31 45.84 28.85
Research & Development 2.62 5.39 9.02 34.79 15.56 9.21 52.32 50.31 53.65 33.96 22.52
Selling, General and Administrative 4.32 8.14 12.14 8.7 4.62 4.39 12.42 13.93 10.26 11.57 6.05
Other Operating Expenses 7.06 0 -0.009 -0.734 -0.669 0 1.41 1.78 1.4 0.306 0.272
Operating Income -6.93 -13.53 -15.72 -41.53 -11.09 -3.12 -61.15 -63.18 -59.97 -37.45 -24.53
Net Non-Operating Interest -0.24 -0.027 -0.012 0 0 0 1.09 0.872 0.641 0.246 -0.599
Interest Income -0.229 0.111 0.325 3.74 1.29 4.96 1.09 0.872 0.641 0.246 0
Interest Expense 0.011 0.138 0.337 3.74 1.29 4.96 0 0 0 0 0.599
Equity & Other Income/(Expense) -0.511 -3.57 1.66 -21.92 -0.724 -4 0.936 0.478 -0.1 -0.023 0.093
Income Before Tax -7.68 -17.13 -14.08 -63.45 -11.82 -7.11 -59.12 -61.83 -59.43 -37.23 -25.04
Income Tax Expense 0.018 0 0 -0.386 0.143 6.76 0 0 0 0 0
Income Attributable to Non-Controlling Interest -0.001 0 0.023 0 0 0 0 0 0 0 0
Net Income -7.7 -17.13 -14.1 -63.07 -11.96 -13.88 -59.12 -61.83 -59.43 -37.23 -25.04
Depreciation and Amortization -0.006 0 0.009 0.734 0.669 3.27 1.41 1.78 1.4 0.306 0.272
EBITDA -6.94 -13.53 -15.71 -40.8 -10.42 0.156 -59.74 -61.4 -58.57 -37.15 -24.26
Earnings Per Share (EPS) -0.53 -1.42 -1.28 -12.8 -8.14 -41.26 -161.9 -224.9 -327.5 -277.9 -140.8
Diluted Earnings Per Share -0.53 -1.42 -1.28 -12.8 -8.14 -41.26 -161.9 -224.9 -327.5 -277.9 -140.8
Weighted Average Shares Outstanding 12.9 12.1 11.05 4.93 1.47 0.336 0.365 0.275 0.181 0.134 0.178
Diluted Weighted Average Shares Outstanding 12.9 12.1 11.05 4.93 1.47 0.336 0.365 0.275 0.181 0.134 0.178
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us